BSEResult22h ago · 13 Aug 2026, 06:22 pm

Un-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.2026

Bandaram Pharma Packtech Ltd · 524602

✦ AI SummaryResults

Bandaram Pharma Packtech Ltd has announced its un-audited financial results for the quarter ended 30.06.2026. The company has considered and approved the un-audited financial results along with the limited review report for the quarter. Additionally, the board has re-appointed Mr. Suryaprakasa Rao Bommisetti as an independent director for a 2nd term of 5 consecutive years and re-appointed M/s. M.M. Reddy & Co. as statutory auditors for a period of 3 years.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bandaram Pharma Packtech Ltd - 524602 - Un-Audited Financial Results (Standalone & Consolidated) For The Quater Ended 30.06.2026

Attachments (1)

📄

6092e62a-87ff-4aa0-a5aa-b1f8c3366835.pdf

pdf

Download →
View document text
FNCIFREM Date: 13.08.2026 BSE Limited P.J. Towers, Dalal Street Mumbai - 400001 Sub: Outcome of Board Meeting held on 13.08.2026 under Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Company’s Letter dated 06.08.2026 Unit: Bandaram Pharma Packtech Limited (Scrip Code: 524602) Dear Sir/Madam, With reference to the above-mentioned subject, this is to inform the Exchange that the meeting of Board of Directors of Bandaram Pharma Packtech Limited was held on Thursday, the 13th day of August, 2026 at 04.00 p.m. at the Registered Office of the Company at 601,5th Floor, Oxford Towers, opp to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore, Bangalore, Karnataka, India, 560008. The Board has inter-alia considered and approved the following items: 1. Un-audited financial Results (Standalone and Consolidated) along with the Limited Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026. (Enclosed) 2. Re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director of the Company for 2nd term of 5 consecutive years w.e.f., 07.03.2027, subject to the approval of the members in ensuing annual general meeting. (Details annexed as Annexure A) 3. Re-appointment of M/s. M.M. Reddy & Co., Chartered Accountants as statutory auditors of the company for a period of 3 years from the conclusion of this Annual general Meeting to Annual general Meeting for the FY 2028-29, subject to the approval of the members in ensuing annual general meeting. (Details annexed as Annexure A) Web: www.bandaram.com E.=.n:1.=IR.=.n4 PHFRM PFEKTEEH LIMITED CIN:L93090KA1993PLC159827 Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodihalli, Bangalore-560008 EMail: info.bandorom@gmaiI.com Phone No. 08040952127 FNCIFREM 4. Director’s Report for FY 2025-26 and notice for convening Annual General Meeting (AGM) for the Financial Year 2025-26. 5. Annual General meeting for the FY 2025-26 is scheduled to be held on Friday, 18.09.2026 at 11:00 a.m. through Video Conference/other Audio-visual means (OAVM). The meeting concluded at 05.10 p.m. We request you to kindly take note of the same in your records. Thanking you. Yours sincerely, For Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Chairman and Managing Director (DIN: 07074102) Encl: a/a Web: www.bandaram.com a.=.n:1.=IR.=.m FHFRM PFEKTEEH LIMITED CIN:L93090KA1993PLC159827 Oxfordtowers, Unit No. 601, 5th Floor OldAirport Rood, Kodihalli, Bongolore-560008 EMail: info.bandorom@gmoil.com Phone No. 08040952127 FNCIFREM Annexure A Disclosures as required under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Particulars Mr. Suryaprakasa Rao M/s. M.M. Reddy & Co., Bommisetti Chartered Accountants Reason for change viz. Re-appointment of R e - a p p o i n t m e n t o f M/s. M.M. Resignation/ Mr. Suryaprakasa Rao Bommisetti Reddy & Co., Chartered appointment as Independent Director of the Accountants as Statutory Company. Auditors of the Company. Date of Re-appointment for a term of 5 Terms of appointment: Re- Appointment/Cessation years w.e.f. 07.03.2027. appointment for 2nd term of 3 and Terms of consecutive years from the appointment conclusion of Annual General Meeting for FY 2025-26 until the conclusion of Annual General Meeting for FY 2028- 29 as recommended by the Audit Committee and approved by the Board of Directors. Brief profile Mr. Suryaprakasa Rao Bommisetti, M M REDDY & CO., qualified in 1995, has over 31 years Chartered Accountants is a of experience in banking, auditing, partnership firm established on finance, and consultancy. He 22 September 2003, with worked for 5½ years in a Bank offices across Telangana, handling audits, compliance, MIS Andhra Pradesh, and reporting, statutory audit Karnataka, and associate coordination, corporate advances, presence in Dubai, Singapore, NPAs, and recovery matters. In and Hong Kong. With 9 practice, he has managed accounts partners and a team of 30+ finalization across diverse sectors, professionals, the firm offers ROC and incorporation matters, and specialized expertise in audit, liaison with RBI and government taxation, advisory, forensic departments. His expertise covers audits, information systems Web: www.bandaram.com E.=.n:J.=IR.=m1 FHFRM FFEKTEEH LIMITED CIN:L93090KA1993PLC159827 Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodiholli, Bangalore-560008 EMail: info.bandoram@gmaiI.com Phone No. 08040952127 FNCIFREM accounting, audit, finance, advisory, audits, insolvency, government and consultancy services. He has audits, stock audits, and public also completed ICAI’s certificate finance. It is empanelled with courses on Concurrent Audit of premier institutions including Banks, Ind AS, and Public Finance IBA, CBI, SFIO, Telangana & Government Accounting, along Police (EOW), SBI, IDBI, with training from ICAI Registered SIDBI, IFCI, and major public Valuers Organization. sector banks for forensic and specialized audit assignments. The firm has extensive experience in stock audits, concurrent audits, statutory branch audits, and large corporate banking assignments, and currently serves as Statutory Branch Auditor for SBI and concurrent auditor for leading bank branches. Disclosure of Nil Not Applicable relationships between directors (in case of appointment of a director) Affirmation that the To the best of our knowledge and Not Applicable Director being information, we hereby affirm that appointed is not Mr. Suryaprakasa Rao Bommisetti debarred from holding is not debarred from holding the the office of director office of Director by virtue of any by virtue of any SEBI SEBI order or any other such order or any other such authority. authority Shareholding if any NIL Not Applicable Web: www.bandaram.com EENEFREM FHFRM PFEKTEEH LIMITEEI CIN:L93090KA1993PLC159827 Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodihalli, Bangalore-560008 EMoll: info.bondoram@gmoil.com Phone No. 08040952127 BANDARAM PHARMA PACKTECH LIMITED CIN: L93090KA1993PLC159827 Regd Office: 601, 5th Floor, Oxford Towers, Opp. to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore - 560008. STATEMENT OF STANDALONE AND CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30-06-2026 (Amtount Rs. in lakhs) STANDALONE CONSOLIDATED For the Quarter ended Year ended For the Quarter ended Year ended S.No. Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudited) (Audited) (Unadited) (Audited) (Unaudited) (Audited) (Unadited) (Audited) I. Revenue from Operations 298.51 819.65 75.74 1,095.99 2,395.26 2,625.92 810.37 6 ,292.32 II. Other Income - - - 0.83 0.03 0.97 - 1 .80 III. Total income (I+II) 298.51 819.65 75.74 1,096.82 2,395.29 2,626.89 810.37 6,294.12 IV. Expenses (a) Cost of Materials consumed 276.41 785.79 79.79 1,060.43 2,161.36 2,362.71 648.37 5 ,502.14 (b) Purchase of stock-in-trade - - -4.40 - - - - - (c) Changes in inventories of finished - - - - -85.25 -109.51 -6.17 goods, - 116.86 w(do) rEkm-inp-lopyroeeg rbeesns eafnitsd esxtopcekn-sines-trade 28.17 54.63 10.74 87.75 73.16 225.48 54.60 3 90.65 (e) Finance Cost - - - 0.03 41.66 45.90 46.02 1 50.57 (f) Depreciation and amortisation expenses - 0.05 0.05 0.21 20.37 24.87 13.44 97.37 (h)Other expenses 29.61 12.47 16.41 64.42 91.50 65.74 50.56 2 26.12 Total Expenses 3 34.19 8 52.94 1 02.59 1,212.84 2 ,302.80 2 ,615.19 8 06.82 6,249.99 V. Profit / (Loss) before and exceptional items and Tax ( III-IV) (35.68) (33.29) (26.85) (116.02) 92.49 11.70 3.55 44.13 VI. Exeptional Items - - - - - - - - VII Profit / (Loss) from before tax (V-VI) (35.68) (33.29) (26.85) (116.02) 92.49 11.70 3.55 44.13 VIII. Tax expense Current Tax - - - - 24.05 3.04 0.89 1 1.47 Deferred Tax - ( 0.11) - (0.11) - ( 0.50) 0.19 4.51 IX. [Showing first 8,000 characters — download PDF for full document]